 Mirum Pharmaceuticals, Inc. NASDAQ:MIRM Q3 2022 Results Conference Call November 9, 2022 8:00 AM ET Company Participants Ian Clements - CFO Chris Peetz - President, CEO Director Peter Radovich - COO Pamela Vig - Head of RD Richard Thompson - Professor, Kings College London Conference Call Participants Jessica Fye - JPMorgan Steve Seedhouse - Raymond James Mani Foroohar - SVB Securities David Lebowitz - Citi Yasmeen Rahimi - Piper Sandler Thomas Yip - H.C. Wainwright Operator Hello, everyone, and welcome to the Mirum Q3 2022 Business Update. 